Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

被引:1103
|
作者
Lipinski, Christopher A. [1 ]
Lombardo, Franco [1 ]
Dominy, Beryl W. [1 ]
Feeney, Paul J. [1 ]
机构
[1] Pfizer Inc, Div Cent Res, Groton, CT 06340 USA
关键词
Rule of 5; Computational alert; Poor absorption or permeation; MWT; MLogP; H-Bond donors and acceptors; Turbidimetric solubility; Thermodynamic solubility; Solubility calculation; WATER PARTITION-COEFFICIENTS; AQUEOUS SOLUBILITY; ORGANIC-COMPOUNDS; THEORETICAL DESCRIPTORS; MELTING-POINT; OCTANOL; PARAMETER; CONSTRUCTION; ABSORPTION; PREDICTION;
D O I
10.1016/j.addr.2012.09.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described. In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the molecular weight (MWT) is greater than 500 and the calculated Log P (CLogP) is greater than 5 (or MlogP>4.15). Computational methodology for the rule-based Moriguchi Log P (MLogP) calculation is described. Turbidimetric solubility measurement is described and applied to known drugs. High throughput screening (FITS) leads tend to have higher MWT and Log P and lower turbidimetric solubility than leads in the pre-HTS era. In the development setting, solubility calculations focus on exact value prediction and are difficult because of polymorphism. Recent work on linear free energy relationships and Log P approaches are critically reviewed. Useful predictions are possible in closely related analog series when coupled with experimental thermodynamic solubility measurements. (C) 2012 Published by Elsevier B.V.
引用
收藏
页码:4 / 17
页数:14
相关论文
共 50 条
  • [31] Computational Approaches and Drug Discovery: Where Are We Going?
    Tutone, Marco
    Almerico, Anna Maria
    MOLECULES, 2024, 29 (05):
  • [32] Advancements in Computational Approaches for Antidiabetic Drug Discovery: A Review
    Rossafi, Bouchra
    Abchir, Oussama
    El Kouali, Mhammed
    Chtita, Samir
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024,
  • [33] Editorial: Computational Approaches in Drug Discovery and Precision Medicine
    Huang, Zunnan
    Yao, Xiao Jun
    Gu, Ruo-Xu
    FRONTIERS IN CHEMISTRY, 2021, 8
  • [34] Computational drug discovery using deep learning approaches
    Isayev, Olexandr
    Politi, Regina
    Tropsha, Alexander
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [35] Perspective in computational approaches applied to drug discovery problems
    Humblet, Christine
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [36] Drug discovery and the use of computational approaches for infectious diseases
    Marhoefer, Richard J.
    Oellien, Frank
    Selzer, Paul M.
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (08) : 1011 - 1025
  • [37] Discovery of Amoebicidal Compounds by Combining Computational and Experimental Approaches
    Sebastian-Perez, Victor
    Sifaoui, Ines
    Reyes-Batlle, Maria
    Dominguez-De Barros, Angelica
    Lopez-Arencibia, Atteneri
    Campillo, Nuria E.
    Pinero, Jose E.
    Lorenzo-Morales, Jacob
    Gil, Carmen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (02)
  • [38] Strategies to Address Low Drug Solubility in Discovery and Development
    Williams, Hywel D.
    Trevaskis, Natalie L.
    Charman, Susan A.
    Shanker, Ravi M.
    Charman, William N.
    Pouton, Colin W.
    Porter, Christopher J. H.
    PHARMACOLOGICAL REVIEWS, 2013, 65 (01) : 315 - 499
  • [39] High throughput solubility measurement in drug discovery and development
    Alsenz, Jochem
    Kansy, Manfred
    ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 546 - 567
  • [40] Applying computational modeling to drug discovery and development
    Kumar, Neil
    Hendriks, Bart S.
    Janes, Kevin A.
    de Graaf, David
    Lauffenburger, Douglas A.
    DRUG DISCOVERY TODAY, 2006, 11 (17-18) : 806 - 811